NERD: an umbrella term including heterogeneous subpopulations.

PubWeight™: 1.20‹?› | Rank: Top 10%

🔗 View Article (PMID 23528345)

Published in Nat Rev Gastroenterol Hepatol on March 26, 2013

Authors

Edoardo Savarino1, Patrizia Zentilin, Vincenzo Savarino

Author Affiliations

1: Division of Gastroenterology, Department of Surgical, Oncological and Gastroenterological Sciences, University of Padua, Via Giustiniani 2, 35128 Padua, Italy.

Articles citing this

Diagnosis and Management of Functional Heartburn. Am J Gastroenterol (2016) 1.45

Non-erosive reflux disease patients are more complex than the sole endoscopy tells us. Clin Oral Investig (2013) 1.06

Background factors of reflux esophagitis and non-erosive reflux disease: a cross-sectional study of 10,837 subjects in Japan. PLoS One (2013) 1.05

The placebo effect is a relevant factor in evaluating effectiveness of therapies in functional gastrointestinal disorders. J Gastroenterol (2014) 1.04

Esophageal motility abnormalities in gastroesophageal reflux disease. World J Gastrointest Pharmacol Ther (2014) 0.99

Not All Patients With Non-erosive Reflux Disease Share Psychological Distress as Main Mechanism of Disease. J Neurogastroenterol Motil (2014) 0.96

Therapeutic potential of curcumin in digestive diseases. World J Gastroenterol (2013) 0.92

Effective and safe proton pump inhibitor therapy in acid-related diseases - A position paper addressing benefits and potential harms of acid suppression. BMC Med (2016) 0.92

Pathophysiology of functional heartburn based on Rome III criteria in Japanese patients. World J Gastroenterol (2015) 0.88

Tryciclic Antidepressants in Refractory GERD: Poorly Effective Drugs or Wrong Patients? Am J Gastroenterol (2016) 0.85

EAES recommendations for the management of gastroesophageal reflux disease. Surg Endosc (2014) 0.84

Symptom analysis improves GERD diagnosis and may be helpful to define a successful surgical approach. Surg Endosc (2013) 0.82

Impairment of chemical clearance and mucosal integrity distinguishes hypersensitive esophagus from functional heartburn. J Gastroenterol (2016) 0.80

Distinction between patients with non-erosive reflux disease and functional heartburn. Ann Gastroenterol (2013) 0.79

Functional Heartburn Overlaps With Irritable Bowel Syndrome More Often than GERD. Am J Gastroenterol (2016) 0.77

Autofluorescence imaging endoscopy can distinguish non-erosive reflux disease from functional heartburn: A pilot study. World J Gastroenterol (2016) 0.77

Laparoscopic fundoplication for gastroesophageal reflux disease. World J Gastroenterol (2014) 0.76

Not all anti-reflux treatment failures are due to persistence of abnormal esophageal acid exposure. Surg Endosc (2013) 0.76

Irsogladine maleate and rabeprazole in non-erosive reflux disease: A double-blind, placebo-controlled study. World J Gastroenterol (2015) 0.76

Expert consensus document: Advances in the physiological assessment and diagnosis of GERD. Nat Rev Gastroenterol Hepatol (2017) 0.76

Randomised clinical trial: mucosal protection combined with acid suppression in the treatment of non-erosive reflux disease - efficacy of Esoxx, a hyaluronic acid-chondroitin sulphate based bioadhesive formulation. Aliment Pharmacol Ther (2017) 0.75

Esophageal testing: What we have so far. World J Gastrointest Pathophysiol (2016) 0.75

Adult and paediatric GERD: diagnosis, phenotypes and avoidance of excess treatments. Nat Rev Gastroenterol Hepatol (2016) 0.75

The importance of subgrouping refractory NERD patients according to esophageal pH-impedance testing. Surg Endosc (2013) 0.75

A novel prostanoid EP1 receptor antagonist, ONO-8539, reduces acid-induced heartburn symptoms in healthy male volunteers: a randomized clinical trial. J Gastroenterol (2017) 0.75

Impedance-pH Monitoring for Diagnosis of Reflux Disease: New Perspectives. Dig Dis Sci (2017) 0.75

Oesophagus: Symptom perception in patients with NERD: do nerves matter? Nat Rev Gastroenterol Hepatol (2017) 0.75

Articles cited by this

(truncated to the top 100)

The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus. Am J Gastroenterol (2006) 12.80

Prevalence and clinical spectrum of gastroesophageal reflux: a population-based study in Olmsted County, Minnesota. Gastroenterology (1997) 8.51

Epidemiology of gastro-oesophageal reflux disease: a systematic review. Gut (2005) 7.35

Laparoscopic antireflux surgery vs esomeprazole treatment for chronic GERD: the LOTUS randomized clinical trial. JAMA (2011) 4.74

A comparison of five maintenance therapies for reflux esophagitis. N Engl J Med (1995) 3.98

Gastro-oesophageal reflux monitoring: review and consensus report on detection and definitions of acid, non-acid, and gas reflux. Gut (2004) 3.85

An evidence-based appraisal of reflux disease management--the Genval Workshop Report. Gut (1999) 3.45

Simultaneous intraesophageal impedance and pH measurement of acid and nonacid gastroesophageal reflux: effect of omeprazole. Gastroenterology (2001) 3.35

Twenty-four hour ambulatory simultaneous impedance and pH monitoring: a multicenter report of normal values from 60 healthy volunteers. Am J Gastroenterol (2004) 3.04

Gastro-oesophageal reflux symptoms, oesophagitis and Barrett's oesophagus in the general population: the Loiano-Monghidoro study. Gut (2008) 2.79

Short-term treatment with proton-pump inhibitors as a test for gastroesophageal reflux disease: a meta-analysis of diagnostic test characteristics. Ann Intern Med (2004) 2.67

Effectiveness of proton pump inhibitors in nonerosive reflux disease. Clin Gastroenterol Hepatol (2004) 2.65

Speed of healing and symptom relief in grade II to IV gastroesophageal reflux disease: a meta-analysis. Gastroenterology (1997) 2.64

Functional esophageal disorders. Gastroenterology (2006) 2.53

Gastro-oesophageal reflux disease in primary care: an international study of different treatment strategies with omeprazole. International GORD Study Group. Eur J Gastroenterol Hepatol (1998) 2.44

Acid, nonacid, and gas reflux in patients with gastroesophageal reflux disease during ambulatory 24-hour pH-impedance recordings. Gastroenterology (2001) 2.41

Subjective and objective data on esophageal manometry and impedance pH monitoring 1 year after endoscopic full-thickness plication for the treatment of GERD by using multiple plication implants. Gastrointest Endosc (2012) 2.38

The role of nonacid reflux in NERD: lessons learned from impedance-pH monitoring in 150 patients off therapy. Am J Gastroenterol (2008) 2.36

Effects of anti-reflux surgery on weakly acidic reflux and belching. Gut (2010) 2.25

A critical analysis, with appropriate controls, of gastric acid and pepsin secretion in clinical esophagitis. Gastroenterology (1991) 2.25

Gastroesophageal reflux and pulmonary fibrosis in scleroderma: a study using pH-impedance monitoring. Am J Respir Crit Care Med (2008) 2.22

Poor effectiveness of proton pump inhibitors in non-erosive reflux disease: the truth in the end! Neurogastroenterol Motil (2012) 2.21

Weakly acidic reflux in patients with chronic unexplained cough during 24 hour pressure, pH, and impedance monitoring. Gut (2005) 2.20

Nonacid reflux in patients with chronic cough on acid-suppressive therapy. Chest (2006) 2.14

High prevalence of gastroesophageal reflux symptoms and esophagitis with or without symptoms in the general adult Swedish population: a Kalixanda study report. Scand J Gastroenterol (2005) 2.13

Reversibility of GERD ultrastructural alterations and relief of symptoms after omeprazole treatment. Am J Gastroenterol (2005) 2.06

Baclofen decreases acid and non-acid post-prandial gastro-oesophageal reflux measured by combined multichannel intraluminal impedance and pH. Aliment Pharmacol Ther (2003) 2.05

The pathogenesis of heartburn in nonerosive reflux disease: a unifying hypothesis. Gastroenterology (2005) 2.00

Esophageal pH-impedance monitoring and symptom analysis in GERD: a study in patients off and on therapy. Am J Gastroenterol (2006) 2.00

Different contributions of ASIC channels 1a, 2, and 3 in gastrointestinal mechanosensory function. Gut (2005) 1.96

PPI therapy is equally effective in well-defined non-erosive reflux disease and in reflux esophagitis: a meta-analysis. Neurogastroenterol Motil (2012) 1.80

Erosive esophagitis and nonerosive reflux disease (NERD): comparison of epidemiologic, physiologic, and therapeutic characteristics. J Clin Gastroenterol (2007) 1.79

Efficacy of venlafaxine for symptomatic relief in young adult patients with functional chest pain: a randomized, double-blind, placebo-controlled, crossover trial. Am J Gastroenterol (2010) 1.75

Non-erosive reflux disease (NERD)--acid reflux and symptom patterns. Aliment Pharmacol Ther (2003) 1.69

Presence of gas in the refluxate enhances reflux perception in non-erosive patients with physiological acid exposure of the oesophagus. Gut (2007) 1.66

Combined multichannel intraluminal impedance-pH monitoring to select patients with persistent gastro-oesophageal reflux for laparoscopic Nissen fundoplication. Br J Surg (2006) 1.66

Prospective follow-up data from the ProGERD study suggest that GERD is not a categorial disease. Am J Gastroenterol (2006) 1.62

Dilated intercellular spaces of esophageal epithelium in nonerosive reflux disease patients with physiological esophageal acid exposure. Am J Gastroenterol (2005) 1.60

Lowered oesophageal sensory thresholds in patients with symptomatic but not excess gastro-oesophageal reflux: evidence for a spectrum of visceral sensitivity in GORD. Gut (1995) 1.58

Normal values and day-to-day variability of 24-h ambulatory oesophageal impedance-pH monitoring in a Belgian-French cohort of healthy subjects. Aliment Pharmacol Ther (2005) 1.57

Prevalence and risk factors for overlaps between gastroesophageal reflux disease, dyspepsia, and irritable bowel syndrome: a population-based study. Digestion (2009) 1.57

Limited ability of the proton-pump inhibitor test to identify patients with gastroesophageal reflux disease. Clin Gastroenterol Hepatol (2012) 1.54

Omeprazole 10 milligrams once daily, omeprazole 20 milligrams once daily, or ranitidine 150 milligrams twice daily, evaluated as initial therapy for the relief of symptoms of gastro-oesophageal reflux disease in general practice. Scand J Gastroenterol (1997) 1.52

Functional heartburn: the stimulus, the pain, and the brain. Gut (2002) 1.51

Review article: alginate-raft formulations in the treatment of heartburn and acid reflux. Aliment Pharmacol Ther (2000) 1.49

Functional heartburn has more in common with functional dyspepsia than with non-erosive reflux disease. Gut (2009) 1.49

Functional heartburn: clinical characteristics and outcome. Eur J Gastroenterol Hepatol (2013) 1.47

Circadian pattern of intragastric acidity in patients with non-erosive reflux disease (NERD). Aliment Pharmacol Ther (2003) 1.44

Accuracy of the diagnosis of GORD by questionnaire, physicians and a trial of proton pump inhibitor treatment: the Diamond Study. Gut (2010) 1.44

Pathophysiological characteristics of the various forms of gastro-oesophageal reflux disease. Spectrum disease or distinct phenotypic presentations? Dig Liver Dis (2006) 1.42

Gastroesophageal reflux disease--should we adopt a new conceptual framework? Am J Gastroenterol (2002) 1.42

Barrett's esophagus: prevalence and size of hiatal hernia. Am J Gastroenterol (1999) 1.41

Esophageal pH-impedance monitoring in patients with therapy-resistant reflux symptoms: 'on' or 'off' proton pump inhibitor? Am J Gastroenterol (2008) 1.39

Natural history of gastro-oesophageal reflux disease without oesophagitis. Gut (1991) 1.38

The added value of impedance-pH monitoring to Rome III criteria in distinguishing functional heartburn from non-erosive reflux disease. Dig Liver Dis (2011) 1.37

Predictive factors of the long term outcome in gastro-oesophageal reflux disease: six year follow up of 107 patients. Gut (1994) 1.33

Randomized trial of sertraline in patients with unexplained chest pain of noncardiac origin. Am Heart J (2000) 1.33

Reassessment of the diagnostic value of histology in patients with GERD, using multiple biopsy sites and an appropriate control group. Am J Gastroenterol (2005) 1.33

Overlap of gastro-oesophageal reflux disease and irritable bowel syndrome: prevalence and risk factors in the general population. Aliment Pharmacol Ther (2007) 1.32

Characteristics of reflux episodes and symptom association in patients with erosive esophagitis and nonerosive reflux disease: study using combined impedance-pH off therapy. Am J Gastroenterol (2009) 1.32

Acid and weakly acidic solutions impair mucosal integrity of distal exposed and proximal non-exposed human oesophagus. Gut (2009) 1.31

Esophageal dilated intercellular spaces (DIS) and nonerosive reflux disease. Am J Gastroenterol (2007) 1.30

Impedance-pH reflux patterns can differentiate non-erosive reflux disease from functional heartburn patients. J Gastroenterol (2011) 1.29

Microscopic esophagitis distinguishes patients with non-erosive reflux disease from those with functional heartburn. J Gastroenterol (2012) 1.28

Normal values of 24-h ambulatory intraluminal impedance combined with pH-metry in subjects eating a Mediterranean diet. Dig Liver Dis (2006) 1.26

Short exposure of oesophageal mucosa to bile acids, both in acidic and weakly acidic conditions, can impair mucosal integrity and provoke dilated intercellular spaces. Gut (2008) 1.24

Rabeprazole in nonerosive gastroesophageal reflux disease: a randomized placebo-controlled trial. Am J Gastroenterol (2002) 1.23

The effect of auditory stress on perception of intraesophageal acid in patients with gastroesophageal reflux disease. Gastroenterology (2007) 1.19

Diagnosis and management of non-erosive reflux disease--the Vevey NERD Consensus Group. Digestion (2009) 1.19

Sustained esophageal contraction: a motor correlate of heartburn symptom. Am J Physiol Gastrointest Liver Physiol (2001) 1.19

Visceral hypersensitivity in non-erosive reflux disease. Gut (2007) 1.18

Capsaicin receptor (TRPV1) and non-erosive reflux disease. Eur J Gastroenterol Hepatol (2006) 1.17

Proinflammatory cytokines alter/reduce esophageal circular muscle contraction in experimental cat esophagitis. Am J Physiol Gastrointest Liver Physiol (2004) 1.17

Predominant nocturnal acid reflux in patients with Los Angeles grade C and D reflux esophagitis. J Gastroenterol Hepatol (2001) 1.15

Characteristics of symptomatic reflux episodes on Acid suppressive therapy. Am J Gastroenterol (2008) 1.14

Gastro-oesophageal reflux and aspiration of gastric contents in adult patients with cystic fibrosis. Gut (2008) 1.14

Oesophageal motility and bolus transit abnormalities increase in parallel with the severity of gastro-oesophageal reflux disease. Aliment Pharmacol Ther (2011) 1.12

How many cases of laryngopharyngeal reflux suspected by laryngoscopy are gastroesophageal reflux disease-related? World J Gastroenterol (2012) 1.11

Proton-gated cation channels--neuronal acid sensors in the central and peripheral nervous system. Adv Exp Med Biol (2001) 1.11

Esomeprazole 20 mg maintains symptom control in endoscopy-negative gastro-oesophageal reflux disease: a controlled trial of 'on-demand' therapy for 6 months. Aliment Pharmacol Ther (2001) 1.09

Proton pump inhibitors in GORD An overview of their pharmacology, efficacy and safety. Pharmacol Res (2008) 1.09

Selective serotonin reuptake inhibitors for the treatment of hypersensitive esophagus: a randomized, double-blind, placebo-controlled study. Am J Gastroenterol (2011) 1.06

Combined multichannel intraluminal impedance and pH-metry: a novel technique to improve detection of gastro-oesophageal reflux literature review. Dig Liver Dis (2004) 1.06

Mechanisms of reflux perception in gastroesophageal reflux disease: a review. Am J Gastroenterol (2012) 1.04

Nonerosive Reflux Disease (NERD) - An Update. J Neurogastroenterol Motil (2010) 1.04

Microscopic esophageal mucosal injury in nonerosive reflux disease. Clin Gastroenterol Hepatol (2006) 1.02

Increased TRPV1 gene expression in esophageal mucosa of patients with non-erosive and erosive reflux disease. Neurogastroenterol Motil (2010) 1.01

Long-term outcome of microscopic esophagitis in chronic GERD patients treated with esomeprazole or laparoscopic antireflux surgery in the LOTUS trial. Am J Gastroenterol (2009) 1.00

Long-term outcome from tricyclic antidepressant treatment of functional chest pain. Dig Dis Sci (1999) 1.00

Quantitative assessment and characterization of visceral hyperalgesia evoked by esophageal balloon distention and acid perfusion in patients with functional heartburn, nonerosive reflux disease, and erosive esophagitis. Clin J Pain (2010) 0.99

Reflux patterns in patients with short-segment Barrett's oesophagus: a study using impedance-pH monitoring off and on proton pump inhibitor therapy. Aliment Pharmacol Ther (2009) 0.98

Oesophageal acid hypersensitivity is not a contraindication to Nissen fundoplication. Br J Surg (2009) 0.97

Esomeprazole 20 mg on-demand is more acceptable to patients than continuous lansoprazole 15 mg in the long-term maintenance of endoscopy-negative gastro-oesophageal reflux patients: the COMMAND Study. Aliment Pharmacol Ther (2004) 0.96

Refractory heartburn: comparison of intercellular space diameter in documented GERD vs. functional heartburn. Am J Gastroenterol (2010) 0.94

Functional heartburn: definition and management strategies. Curr Gastroenterol Rep (2012) 0.94

Regional oesophageal sensitivity to acid and weakly acidic reflux in patients with non-erosive reflux disease. Neurogastroenterol Motil (2008) 0.94

On-demand therapy for gastroesophageal reflux disease. Am J Gastroenterol (2007) 0.94

Systematic review: does gastro-oesophageal reflux disease progress? Aliment Pharmacol Ther (2006) 0.93

Reflux parameters as modified by laparoscopic fundoplication in 40 patients with heartburn/regurgitation persisting despite PPI therapy: a study using impedance-pH monitoring. Dig Dis Sci (2010) 0.93

Characteristics of gastro-esophageal reflux episodes in Barrett's esophagus, erosive esophagitis and healthy volunteers. Neurogastroenterol Motil (2010) 0.92

Articles by these authors

Mongersen, an oral SMAD7 antisense oligonucleotide, and Crohn's disease. N Engl J Med (2015) 6.71

Liver enzyme alteration: a guide for clinicians. CMAJ (2005) 3.42

Platelet count/spleen diameter ratio for the noninvasive diagnosis of esophageal varices: results of a multicenter, prospective, validation study. Am J Gastroenterol (2006) 2.64

The role of nonacid reflux in NERD: lessons learned from impedance-pH monitoring in 150 patients off therapy. Am J Gastroenterol (2008) 2.36

Management strategy for patients with gastroesophageal reflux disease: a comparison between empirical treatment with esomeprazole and endoscopy-oriented treatment. Am J Gastroenterol (2008) 2.32

Gastroesophageal reflux and pulmonary fibrosis in scleroderma: a study using pH-impedance monitoring. Am J Respir Crit Care Med (2008) 2.22

An inter- and intra-laboratory comparison of breath ¹³CO₂analysis. Aliment Pharmacol Ther (2003) 2.03

Adalimumab is more effective than azathioprine and mesalamine at preventing postoperative recurrence of Crohn's disease: a randomized controlled trial. Am J Gastroenterol (2013) 1.65

Small intestinal bacterial overgrowth in rosacea: clinical effectiveness of its eradication. Clin Gastroenterol Hepatol (2008) 1.59

Peripheral blood cytopaenia limiting initiation of treatment in chronic hepatitis C patients otherwise eligible for antiviral therapy. Liver Int (2012) 1.53

Prevention of postoperative recurrence of Crohn's disease by Adalimumab: a case series. Eur J Gastroenterol Hepatol (2012) 1.47

Can Helicobacter pylori eradication regimens be shortened in clinical practice? An open-label, randomized, pilot study of 4 and 7-day triple therapy with rabeprazole, high-dose levofloxacin, and tinidazole. J Clin Gastroenterol (2006) 1.43

The added value of impedance-pH monitoring to Rome III criteria in distinguishing functional heartburn from non-erosive reflux disease. Dig Liver Dis (2011) 1.37

Reassessment of the diagnostic value of histology in patients with GERD, using multiple biopsy sites and an appropriate control group. Am J Gastroenterol (2005) 1.33

Characteristics of reflux episodes and symptom association in patients with erosive esophagitis and nonerosive reflux disease: study using combined impedance-pH off therapy. Am J Gastroenterol (2009) 1.32

Impedance-pH reflux patterns can differentiate non-erosive reflux disease from functional heartburn patients. J Gastroenterol (2011) 1.29

Microscopic esophagitis distinguishes patients with non-erosive reflux disease from those with functional heartburn. J Gastroenterol (2012) 1.28

Gastro-oesophageal reflux and gastric aspiration in idiopathic pulmonary fibrosis patients. Eur Respir J (2013) 1.12

How many cases of laryngopharyngeal reflux suspected by laryngoscopy are gastroesophageal reflux disease-related? World J Gastroenterol (2012) 1.11

Non-erosive reflux disease is more complex than negative endoscopy only. Am J Gastroenterol (2013) 1.09

Which anticoagulant drug should be used to treat portal vein thrombosis in patients with chronic liver disease? Clin Gastroenterol Hepatol (2012) 1.07

Comment to "predictors of clinical response of acid suppression in Chinese patients with gastroesophageal reflux disease". Dig Liver Dis (2013) 1.07

Esophageal acid exposure still plays a major role in patients with NERD. J Gastroenterol (2013) 1.06

Non-erosive reflux disease patients are more complex than the sole endoscopy tells us. Clin Oral Investig (2013) 1.06

Overlap of functional heartburn and gastroesophageal reflux disease with irritable bowel syndrome. World J Gastroenterol (2013) 1.05

The placebo effect is a relevant factor in evaluating effectiveness of therapies in functional gastrointestinal disorders. J Gastroenterol (2014) 1.04

External validation of the platelet count/spleen diameter ratio for the diagnosis of esophageal varices in hepatitis C virus-related cirrhosis. Dig Dis Sci (2008) 1.02

A 10-day levofloxacin-based therapy in patients with resistant Helicobacter pylori infection: a controlled trial. Clin Gastroenterol Hepatol (2004) 1.01

CDKN2A is the main susceptibility gene in Italian pancreatic cancer families. J Med Genet (2012) 1.00

Elevations in alanine aminotransferase levels late in the course of antiviral therapy in hepatitis C virus RNA-negative patients are associated with virological relapse. Hepatology (2009) 1.00

Small intestinal bacterial overgrowth in patients suffering from scleroderma: clinical effectiveness of its eradication. Am J Gastroenterol (2008) 0.99

Positive glucose breath testing is more prevalent in patients with IBS-like symptoms compared with controls of similar age and gender distribution. J Clin Gastroenterol (2009) 0.99

Alpha-fetoprotein has no prognostic role in small hepatocellular carcinoma identified during surveillance in compensated cirrhosis. Hepatology (2012) 0.99

Prevalence and treatment of Helicobacter pylori in patients with blepharitis. Invest Ophthalmol Vis Sci (2006) 0.97

Thrombocytopenia in liver disease. Curr Opin Hematol (2008) 0.96

Influence of clinically significant portal hypertension on survival after hepatic resection for hepatocellular carcinoma in cirrhotic patients. Liver Int (2013) 0.94

Overweight is a risk factor for both erosive and non-erosive reflux disease. Dig Liver Dis (2011) 0.94

Reassessment of the role of methane production between irritable bowel syndrome and functional constipation. J Gastrointestin Liver Dis (2012) 0.93

Burden of illness in Italian patients with gastro-oesophageal reflux disease. Curr Med Res Opin (2005) 0.93

A significant proportion of patients with chronic hepatitis B who are candidates for antiviral treatment are untreated: A region-wide survey in Italy. J Clin Gastroenterol (2009) 0.91

Role of partially hydrolyzed guar gum in the treatment of irritable bowel syndrome. Nutrition (2006) 0.90

Gastrointestinal motility disorder assessment in systemic sclerosis. Rheumatology (Oxford) (2013) 0.90

Optimal treatment of laryngopharyngeal reflux disease. Ther Adv Chronic Dis (2013) 0.90

The pharmacokinetics of ilaprazole for gastro-esophageal reflux treatment. Expert Opin Drug Metab Toxicol (2013) 0.88

Hepatocellular carcinoma in patients with cryptogenic cirrhosis. Clin Gastroenterol Hepatol (2009) 0.87

Defining esophageal landmarks, gastroesophageal reflux disease, and Barrett's esophagus. Ann N Y Acad Sci (2013) 0.86

Incidence of bleeding following invasive procedures in patients with thrombocytopenia and advanced liver disease. Clin Gastroenterol Hepatol (2010) 0.85

[Possible connection between gastroesophageal reflux and interstitial pulmonary fibrosis in patients with systemic sclerosis]. Recenti Prog Med (2009) 0.84

The role of Acid in functional dyspepsia. Am J Gastroenterol (2011) 0.84

Use of the platelet count/spleen diameter ratio for the noninvasive diagnosis of esophageal varices in patients with schistosomiasis. Saudi J Gastroenterol (2011) 0.84

The Italian validation of the Montreal Global definition and classification of gastroesophageal reflux disease. Eur J Gastroenterol Hepatol (2009) 0.83

Microscopic esophagitis and Barrett's esophagus: the histology report. Dig Liver Dis (2011) 0.83

Narrow-band imaging with magnifying endoscopy is accurate for detecting gastric intestinal metaplasia. World J Gastroenterol (2013) 0.83

Hepatocellular carcinoma in patients without cirrhosis in Italy. Dig Liver Dis (2012) 0.83

Achalasia with dense eosinophilic infiltrate responds to steroid therapy. Clin Gastroenterol Hepatol (2011) 0.83

Symptom patterns can distinguish diverticular disease from irritable bowel syndrome. Eur J Clin Invest (2013) 0.83

Alginate controls heartburn in patients with erosive and nonerosive reflux disease. World J Gastroenterol (2012) 0.82

Endotherapy for and tailored approaches to treating GERD, and refractory GERD. Ann N Y Acad Sci (2013) 0.82

Efficacy of 48-hour post-operative antibiotics prophylaxis for patients undergoing percutaneous endoscopic gastrostomy tube in preventing site infection. J Gastrointestin Liver Dis (2011) 0.81

Assessment of dietary fiber fermentation: effect of Lactobacillus reuteri and reproducibility of short-chain fatty acid concentrations. Mol Nutr Food Res (2009) 0.81

Impact of E27X, a novel CDKN2A germ line mutation, on p16 and p14ARF expression in Italian melanoma families displaying pancreatic cancer and neuroblastoma. Hum Mol Genet (2006) 0.81

Influence of 1-week Helicobacter pylori eradication therapy with rabeprazole, clarithromycin, and metronidazole on 13C-aminopyrine breath test. Dig Dis Sci (2005) 0.80

Functional testing: pharyngeal pH monitoring and high-resolution manometry. Ann N Y Acad Sci (2013) 0.80

Microscopic esophagitis in gastro-esophageal reflux disease: individual lesions, biopsy sampling, and clinical correlations. Virchows Arch (2008) 0.80

Predicting the risk of pancreatic cancer: on CDKN2A mutations in the melanoma-pancreatic cancer syndrome in Italy. J Clin Oncol (2007) 0.80

Helicobacter pylori infection is associated with greater impairment of cytochrome P-450 liver metabolic activity in anti-HCV positive cirrhotic patients. Dig Dis Sci (2003) 0.79

A comparison between sodium alginate and magaldrate anhydrous in the treatment of patients with gastroesophageal reflux symptoms. Dig Dis Sci (2006) 0.79

Predictive factors for response to peginterferon-alpha and ribavirin treatment of chronic HCV infection in patients aged 65 years and more. Dig Dis Sci (2010) 0.79

Platelet count and survival of patients with compensated cirrhosis and small hepatocellular carcinoma treated with surgery. Hepatology (2014) 0.78

A comparison between lactose breath test and quick test on duodenal biopsies for diagnosing lactase deficiency in patients with self-reported lactose intolerance. J Clin Gastroenterol (2013) 0.78

The use of artificial neural network in gastroenterology: the experience of the first 10 years. Eur J Gastroenterol Hepatol (2007) 0.78

Barrett's esophagus: proton pump inhibitors and chemoprevention II. Ann N Y Acad Sci (2011) 0.78

Evidence of prolonged orocecal transit time and small intestinal bacterial overgrowth in acromegalic patients. J Clin Endocrinol Metab (2007) 0.78

Lactulose breath test to assess oro-cecal transit delay and estimate esophageal dysmotility in scleroderma patients. Semin Arthritis Rheum (2013) 0.78

Light microscopy is useful to better define NERD and functional heartburn. Gut (2013) 0.78